Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2026 05:10 ET | Source: Research and Markets

AI in Oncology for Analytical Solutions Market to Triple in Size During 2026-2030 Registering 34.2% CAGR - IBM Watson Health, NVIDIA Corp., and Siemens Healthineers Dominate the $1.93 Billion Industry

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "AI in Oncology for Analytical Solutions Market Report 2026" has been added to ResearchAndMarkets.com's offering. The AI in oncology for...
March 30, 2026 05:08 ET | Source: Research and Markets

Artificial Intelligence in Oncology: Assessment of Market Opportunities by Region and Market, 2026-2030 - North America Leads but Asia-Pacific is Emerging Fast

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Oncology Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers a comprehensive...
March 27, 2026 12:31 ET | Source: Fight Colorectal Cancer

Colorectal Cancer Advocates Urge Congress to Fund New Research

Washington, D.C., March 27, 2026 (GLOBE NEWSWIRE) -- Fight Colorectal Cancer (Fight CRC), the nation’s leading advocacy organization dedicated to ending colorectal cancer, hosted its 20th Annual...
March 27, 2026 11:12 ET | Source: Research and Markets

Competitive Insights and Expert Consultation on the Growing Oncology Nutrition Market, 2026-2030: A $3.27 Billion Opportunity

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Oncology Nutrition Market Report 2026" has been added to ResearchAndMarkets.com's offering. The oncology nutrition market has shown robust...
March 27, 2026 10:49 ET | Source: Research and Markets

Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Anti-Cancer MAbS Market Report 2026" has been added to ResearchAndMarkets.com's offering. The anti-cancer monoclonal antibodies (mAbs) market has...
March 06, 2026 07:45 ET | Source: Immuneering Corporation

Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
March 05, 2026 07:30 ET | Source: Compass Therapeutics

Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update

In the Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer, the prespecified event threshold of 80% overall survival (OS) events was...
February 27, 2026 14:52 ET | Source: Fight Colorectal Cancer

A Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall

Washington D.C., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Fight Colorectal Cancer (Fight CRC), the nation’s leading advocacy organization dedicated to ending colorectal cancer, will begin its fifth...
February 24, 2026 07:30 ET | Source: Promatix Biosciences, Ltd.

Promatix Biosciences Presents Positive Preclinical Data with First-in-Class PBS293 EGFR×EphA2 Cis-Bispecific ADC Demonstrating Enhanced Tumour Selectivity

Data presented at 16th World ADC London Summit with lead programme in colorectal cancer highlight the promise of Promatix’s proteomics-based platform to optimise cis-bispecific antibody-drug conjugate...
February 18, 2026 08:19 ET | Source: Biomerica, Inc.

Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution

Approval Marks Biomerica’s Strategic Entry into Southeast Asia’s Rapidly Growing Healthcare MarketSimple, FDA-Cleared At-Home Test Detects an Early Warning Sign of Colorectal Cancer in Minutes ...